Literature DB >> 8865106

Metabolic and respiratory effects of sodium lactate during short i.v. nutrition in critically ill patients.

R Chioléro1, P Schneiter, C Cayeux, E Temler, E Jéquier, C Schindler, L Tappy.   

Abstract

BACKGROUND: Hyperglycemia and an increased ventilatory demand secondary to an increased CO2 production are frequent undesirable effects of total parenteral nutrition (TPN) in critically ill patients. This study was performed to assess whether sodium lactate as a metabolic substrate may affect these variables.
METHODS: Five male patients with multiple trauma during the flow phase were studied during two consecutive 3-hour periods of isocaloric (1.1 x resting energy expenditure) TPN. Sixty-five percent of total calories was provided as carbohydrate, 15% as lipids, and 20% as amino acids during the first period (TPN-glucose), whereas 35% carbohydrate, 30% lactate, 20% lipids, and 15% amino acids (TPN-lactate) were substituted during the second period. Respiratory gas exchanges and net substrate oxidation were assessed by means of indirect calorimetry. Glucose kinetics was determined by primed-constant infusion of U-13C glucose.
RESULTS: Compared with TPN-glucose, TPN-lactate decreased glycemia by 20%, insulinemia by 43%, net carbohydrate oxidation (assessed from indirect calorimetry) by 34%, and plasma glucose oxidation (assessed from 13CO2) by 54%. Respiratory oxygen exchange were increased by 3.7% due to a 20% thermic effect of lactate, but respiratory CO2 exchanges did not change. Pao2 decreased by 11.3 mm Hg, indicating that the increased O2 consumption was not matched by an appropriate increase in spontaneous ventilation. Arterial pH increased from 7.41 +/- 0.04 to 7.46 +/- 0.05.
CONCLUSION: Sodium lactate as a metabolic substrate limits hyperglycemia but induces metabolic alkalosis and does not spare the ventilatory demand.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865106     DOI: 10.1177/0148607196020004257

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  5 in total

1.  Lactate and glucose interactions during rest and exercise in men: effect of exogenous lactate infusion.

Authors:  Benjamin F Miller; Jill A Fattor; Kevin A Jacobs; Michael A Horning; Franco Navazio; Michael I Lindinger; George A Brooks
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

2.  Effect of major hepatectomy on glucose and lactate metabolism.

Authors:  R Chioléro; L Tappy; M Gillet; J P Revelly; H Roth; C Cayeux; P Schneiter; X Leverve
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

3.  Hypertonic sodium lactate improves fluid balance and hemodynamics in porcine endotoxic shock.

Authors:  Thibault Duburcq; Raphaël Favory; Daniel Mathieu; Thomas Hubert; Jacques Mangalaboyi; Valery Gmyr; Laurence Quintane; Patrice Maboudou; François Pattou; Mercé Jourdain
Journal:  Crit Care       Date:  2014-08-14       Impact factor: 9.097

4.  Comparison of fluid balance and hemodynamic and metabolic effects of sodium lactate versus sodium bicarbonate versus 0.9% NaCl in porcine endotoxic shock: a randomized, open-label, controlled study.

Authors:  Thibault Duburcq; Arthur Durand; Anne-Frédérique Dessein; Joseph Vamecq; Jean-Claude Vienne; Dries Dobbelaere; Karine Mention; Claire Douillard; Patrice Maboudou; Valery Gmyr; François Pattou; Mercé Jourdain; Fabienne Tamion; Julien Poissy; Daniel Mathieu; Raphaël Favory
Journal:  Crit Care       Date:  2017-05-19       Impact factor: 9.097

5.  Sodium lactate improves renal microvascular thrombosis compared to sodium bicarbonate and 0.9% NaCl in a porcine model of endotoxic shock: an experimental randomized open label controlled study.

Authors:  Thibault Duburcq; Arthur Durand; Antoine Tournoys; Viviane Gnemmi; Valery Gmyr; François Pattou; Mercedes Jourdain; Fabienne Tamion; Emmanuel Besnier; Sebastien Préau; Erika Parmentier-Decrucq; Daniel Mathieu; Julien Poissy; Raphaël Favory
Journal:  Ann Intensive Care       Date:  2018-02-14       Impact factor: 6.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.